BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38466881)

  • 21. Anti-obesity and Gut Microbiota Modulation Effect of Astragalus Polysaccharides Combined with Berberine on High-Fat Diet-Fed Obese Mice.
    Yue SJ; Wang WX; Zhang L; Liu J; Feng WW; Gao H; Tang YP; Yan D
    Chin J Integr Med; 2023 Jul; 29(7):617-625. PubMed ID: 34921647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis.
    Qu Y; Li X; Xu F; Zhao S; Wu X; Wang Y; Xie J
    Front Immunol; 2021; 12():679897. PubMed ID: 34367139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora.
    Yan S; Chang J; Hao X; Liu J; Tan X; Geng Z; Wang Z
    Phytomedicine; 2022 Jul; 102():154217. PubMed ID: 35660350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Berberine Attenuates Hyperuricemia by Regulating Urate Transporters and Gut Microbiota.
    Shan B; Wu M; Chen T; Tang W; Li P; Chen J
    Am J Chin Med; 2022; 50(8):2199-2221. PubMed ID: 36266751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Synbiotic Ameliorates Con A-Induced Autoimmune Hepatitis in Mice through Modulation of Gut Microbiota and Immune Imbalance.
    Liu Q; Yang H; Kang X; Tian H; Kang Y; Li L; Yang X; Liu H; Ren P; Kuang X; Tong M; Fan W
    Mol Nutr Food Res; 2023 Apr; 67(7):e2200428. PubMed ID: 36708241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effect of the total saponin from Panax Japonicus on experimental autoimmune encephalomyelitis by attenuating inflammation and regulating gut microbiota in mice.
    Wang J; He L; Wang S; Zhao H; Chen J; Dong Y; Yasen S; Wang L; Zou H
    J Ethnopharmacol; 2023 Oct; 315():116681. PubMed ID: 37230280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression.
    Yang YN; Wang QC; Xu W; Yu J; Zhang H; Wu C
    Biomed Pharmacother; 2022 Nov; 155():113749. PubMed ID: 36174380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demethyleneberberine attenuates concanavalin A-induced autoimmune hepatitis in mice through inhibition of NF-κB and MAPK signaling.
    Zhang M; Li Q; Zhou C; Zhao Y; Li R; Zhang Y
    Int Immunopharmacol; 2020 Mar; 80():106137. PubMed ID: 31931366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota.
    Fang Y; Zhang J; Zhu S; He M; Ma S; Jia Q; Sun Q; Song L; Wang Y; Duan L
    Pharmacol Res; 2021 Mar; 165():105439. PubMed ID: 33493658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary berberine supplementation improves growth performance and alleviates gut injury in weaned piglets by modulating ileal microbiota and metabolites.
    Zhu C; Le M; He Z; Bai Y; Yang J; Ye J; Chen Z; Jiang Z
    Food Funct; 2023 May; 14(9):4143-4162. PubMed ID: 37060117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Gut Microbiota: A Novel Player in Autoimmune Hepatitis.
    Cheng Z; Yang L; Chu H
    Front Cell Infect Microbiol; 2022; 12():947382. PubMed ID: 35899041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effects of Berberine on the Gut Microbiota in Apc
    Wang H; Guan L; Li J; Lai M; Wen X
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30205580
    [No Abstract]   [Full Text] [Related]  

  • 33. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites.
    Jing W; Dong S; Luo X; Liu J; Wei B; Du W; Yang L; Luo H; Wang Y; Wang S; Lu H
    Pharmacol Res; 2021 Feb; 164():105358. PubMed ID: 33285228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of anti-inflammatory effects of berberine, and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo.
    Li CL; Tan LH; Wang YF; Luo CD; Chen HB; Lu Q; Li YC; Yang XB; Chen JN; Liu YH; Xie JH; Su ZR
    Phytomedicine; 2019 Jan; 52():272-283. PubMed ID: 30599908
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Zhang H; Liu M; Liu X; Zhong W; Li Y; Ran Y; Guo L; Chen X; Zhao J; Wang B; Zhou L
    Front Immunol; 2020; 11():569104. PubMed ID: 33123141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism.
    Wang Y; Shou JW; Li XY; Zhao ZX; Fu J; He CY; Feng R; Ma C; Wen BY; Guo F; Yang XY; Han YX; Wang LL; Tong Q; You XF; Lin Y; Kong WJ; Si SY; Jiang JD
    Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway.
    Dong Y; Fan H; Zhang Z; Jiang F; Li M; Zhou H; Guo W; Zhang Z; Kang Z; Gui Y; Shou Z; Li J; Zhu R; Fu Y; Sarapultsev A; Wang H; Luo S; Zhang G; Hu D
    Int J Biol Sci; 2022; 18(4):1381-1397. PubMed ID: 35280677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactobacillus improves the effects of prednisone on autoimmune hepatitis via gut microbiota-mediated follicular helper T cells.
    Ma L; Zhang L; Zhuang Y; Ding Y; Chen J
    Cell Commun Signal; 2022 Jun; 20(1):83. PubMed ID: 35658901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients.
    Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S
    J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.